4-52020914-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BA1BP4BP7
This summary comes from the ClinGen Evidence Repository: The NM_000232.5: c.*3043A>G variant is located in the 3’UTR of SGCB. Because the variant is located in the 3’UTR, it is not expected to alter the amino acid sequence. The filtering allele frequency of this variant is 0.006250 (the lower threshold of the 95% CI of 460/68042 genome chromosomes) in the European (non-Finnish) population in gnomAD v3.1.2, which is higher than the LGMD VCEP threshold (0.002) for BA1, meeting this criterion (BA1). The computational splicing predictor SpliceAI gives a score of 0.00 for donor and acceptor loss, suggesting that the variant has no impact on splicing (BP4, BP7). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/08/2025): BA1, BP4, BP7. LINK:https://erepo.genome.network/evrepo/ui/classification/CA96772381/MONDO:0015152/184
Frequency
Consequence
NM_000232.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.*3043A>G | 3_prime_UTR_variant | 6/6 | ENST00000381431.10 | NP_000223.1 | ||
SGCB | XM_047416074.1 | c.*3043A>G | 3_prime_UTR_variant | 5/5 | XP_047272030.1 | |||
SGCB | XM_047416075.1 | c.*3043A>G | 3_prime_UTR_variant | 5/5 | XP_047272031.1 | |||
SGCB | XM_047416076.1 | c.*3043A>G | 3_prime_UTR_variant | 5/5 | XP_047272032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431 | c.*3043A>G | 3_prime_UTR_variant | 6/6 | 1 | NM_000232.5 | ENSP00000370839.6 |
Frequencies
GnomAD3 genomes AF: 0.00440 AC: 670AN: 152208Hom.: 6 Cov.: 32
GnomAD4 exome AF: 0.00281 AC: 1AN: 356Hom.: 0 Cov.: 0 AF XY: 0.00459 AC XY: 1AN XY: 218
GnomAD4 genome AF: 0.00439 AC: 669AN: 152326Hom.: 6 Cov.: 32 AF XY: 0.00424 AC XY: 316AN XY: 74492
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy Benign:1
Benign, reviewed by expert panel | curation | ClinGen Limb Girdle Muscular Dystrophy Variant Curation Expert Panel, ClinGen | Jan 08, 2025 | The NM_000232.5: c.*3043A>G variant is located in the 3’UTR of SGCB. Because the variant is located in the 3’UTR, it is not expected to alter the amino acid sequence. The filtering allele frequency of this variant is 0.006250 (the lower threshold of the 95% CI of 460/68042 genome chromosomes) in the European (non-Finnish) population in gnomAD v3.1.2, which is higher than the LGMD VCEP threshold (0.002) for BA1, meeting this criterion (BA1). The computational splicing predictor SpliceAI gives a score of 0.00 for donor and acceptor loss, suggesting that the variant has no impact on splicing (BP4, BP7). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/08/2025): BA1, BP4, BP7. - |
Qualitative or quantitative defects of beta-sarcoglycan Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at